As of 2025-10-31, the Intrinsic Value of BetterLife Pharma Inc (BETR.CN) is -0.03 CAD. This BETR.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.07 CAD, the upside of BetterLife Pharma Inc is -142.55%.
Based on its market price of 0.07 CAD and our intrinsic valuation, BetterLife Pharma Inc (BETR.CN) is overvalued by 142.55%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.03 - -0.03 | -0.03 | -142.55% | 
| DDM - Stable | (0.05) - (0.26) | (0.16) | -339.5% | 
| DDM - Multi | (0.72) - (2.77) | (1.15) | -1864.0% | 
| Market Cap (mil) | 9.87 | 
| Beta | 0.99 | 
| Outstanding shares (mil) | 151.84 | 
| Enterprise Value (mil) | 10.49 | 
| Market risk premium | 5.10% | 
| Cost of Equity | 8.60% | 
| Cost of Debt | 5.00% | 
| WACC | 8.15% |